Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Cash (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Change in Cash for 16 consecutive years, with -$357407.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash fell 1631.12% year-over-year to -$357407.0, compared with a TTM value of -$451066.0 through Sep 2025, up 30.73%, and an annual FY2024 reading of -$796959.0, down 31.48% over the prior year.
  • Change in Cash was -$357407.0 for Q3 2025 at China Pharma Holdings, down from $212344.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $4.4 million in Q4 2021 and bottomed at -$1.5 million in Q2 2022.
  • Average Change in Cash over 5 years is -$36317.3, with a median of -$158664.0 recorded in 2022.
  • The sharpest move saw Change in Cash surged 620.12% in 2021, then crashed 1631.12% in 2025.
  • Year by year, Change in Cash stood at $4.4 million in 2021, then tumbled by 101.28% to -$56327.0 in 2022, then skyrocketed by 195.81% to $53967.0 in 2023, then tumbled by 270.13% to -$91812.0 in 2024, then tumbled by 289.28% to -$357407.0 in 2025.
  • Business Quant data shows Change in Cash for CPHI at -$357407.0 in Q3 2025, $212344.0 in Q2 2025, and -$214191.0 in Q1 2025.